Biotechnology Market Size, Share and Trends 2025 to 2034

Biotechnology Market Size and Forecast 2025 to 2034

The global biotechnology market size is accounted at USD 1.77 billion in 2025 and predicted to increase from USD 2.02 billion in 2026 to approximately USD 5.71 billion by 2034, representing a CAGR of 13.90% from 2025 to 2034.

Biotechnology Market Key Takeaways

• In terms of revenue, the global biotechnology market was valued at USD 1.55 trillion in 2024.
• It is projected to reach USD 5.71 trillion by 2034.
• The market is expected to grow at a CAGR of 13.90% from 2025 to 2034.
• North America accounted for a revenue share of 37.42% in 2024.
• Asia Pacific is expected to grow at the fastest CAGR of 14.8% during the period.
• By application, the bio-pharmacy segment captured the biggest market share of 42% in 2024.
• By application, bio-informatics segments segment is expected to grow at a solid CAGR of 13.2% during the forecast period
• By technology, the tissue engineering and regeneration segment held the highest market share of 19.17% in 2024.
• By technology, the chromatography segment is projected to grow at a solid CAGR of 15.1% during the forecast period

AI in the Market

The biotechnology market is being transformed by artificial intelligence (AI), which not only speeds up the research process but also increases the precision and lowers the cost. One of the significant areas where AI impacts is in drug discovery, where it recognizes new targets, predicts molecules' behavior, and screens compounds effectively. In clinical research, AI works effectively in trial design by predicting the outcome and also through patient selection. AI can do data analysis that is based on gene interpretation, which in turn leads to personalized treatment plans and early disease detection. The manufacturing process also incorporates AI in optimizing the bioprocess parameters, predicting maintenance for the machines, and increasing the yield of the products. Moreover, AI is actively engaged in the already stated processes of the biological reactions as well as in digitalizing the bioinformatics and genomic aspects.

Market Overview

Various government initiatives for the biotechnology market

Union Minister Dr. Jitendra Singh, Minister of State (Independent Charge) for Science and Technology, participated in an exclusive interview with Doordarshan News, where he expressed strong belief that the year 2025 will see India taking a pivotal role in the Global Biotechnology revolution and that India's first Biotechnology policy - BIO-E3 introduced by the Modi Government 3.0 has paved the path for this. 

Congress allocated a total of $7.5 million to support the Agricultural Biotechnology Education and Outreach Initiative, which requests that the U.S. Food and Drug Administration (FDA) deliver education and outreach to the public regarding agricultural biotechnology and food and animal feed products sourced from biotechnology. The FDA collaborated on this initiative alongside the U.S. Department of Agriculture (USDA) and the U.S. Environmental Protection Agency (EPA). 

The European Commission released a communication initiating the EU Biotech and Biomanufacturing Initiative to boost competitiveness and modernize industry. These initiatives aim to promote innovation, enable investment, and establish the EU as a prominent center for biotechnology and biomanufacturing. The initiative outlines eight primary actions, notably: Initiating a study to aid in simplifying and enhancing the EU regulatory framework for biotech (possibly resulting in an EU Biotech Act), Creating an EU Biotech Hub to assist in understanding the regulatory landscape and scaling up, implementing various mechanisms to boost funding and investment in EU biotech and biomanufacturing, Evaluating the EU Bioeconomy Strategy. These actions hold considerable consequences for stakeholders in the EU life sciences ecosystem, particularly regarding the ongoing Pharma Package discussions and the forthcoming EU elections and institutional transitions.

Biotechnology Market Growth Factors

Biotechnology is a branch of science that develops or creates products by utilizing biological systems, living creatures, or elements out of them. Biotechnology now encompasses a wide range of fields such as biochemistry, genetics, and molecular biology. Every year, new technologies and products are developed in fields such as medical, agriculture, and industrial biotechnology.

Due to the rise of the biotechnology sector in developing nations such as China, Japan, and India, the market is being driven by favorable government initiatives. The government activities are aimed at streamlining the medication regulatory pathway, standardizing clinical studies, enhancing reimbursement policies, and expediting the product approval process, all of which will provide the industry with lucrative growth potential.

Furthermore, agricultural input firms are concentrating their efforts on upgrading existing technologies, such as the development of new stacked features in crops and new germplasm through breeding innovations and gene sequencing. The key market players are concentrating their efforts on bringing agricultural innovations to market in order to boost production through long-term solutions.

The rising incidences of target diseases and genetic disorders, as well as continuous technological advancements in Polymerase Chain Reaction (PCR) technologies, the development of miniaturized portable instruments, and the incorporation of robotics, as well as increased investments, funds, and grants for research activities, are driving the growth of the biotechnology market during the forecast period.

The use of genomic analytic techniques such as microbial identification and detection of genetic changes in the diagnosis of major infectious diseases like HIV, malaria, and TB and genetic abnormalities has developed rapidly over the last decade. The expansion in the global prevalence of target diseases, together with the demonstrated usefulness of Polymerase Chain Reaction (PCR) analysis in the diagnosis and estimation of disease-causing bacteria, will drive up the use of clinical diagnostic tests and will ultimately boost the growth of biotechnology market.

The rising frequency of infectious and chronic diseases as well as increased research and development investments to develop breakthrough genomic techniques such as cell based assay and polymerase chain reaction (PCR), are likely to drive significant development in emerging countries. In developing regions, the biotechnology market growth will be aided by the rise in healthcare spending, the expansion of healthcare infrastructure, and lower procedural costs of disease diagnosis techniques.

The expansion of healthcare infrastructure in emerging countries is accompanied by rapid growth of healthcare facilities and modernization. This aspect is contributing to diagnostic laboratories’ increasing demand for clinical diagnostic procedures, which is leading in higher sales and revenue growth of biotechnologies in the market.

Biotechnology is becoming more important since large amounts of data generated by techniques such as nucleic acid and protein acid sequencing require data interpretation and management for medical and future research objectives. Consequently, the biotechnology market is likely to be driven by increased demand over the forecast period.

• The rise of chronic and genetic diseases is a major driving force behind the biotechnology market, and thus, the demand for better diagnostic and therapeutic solutions is increasing.
• Government support is particularly beneficial to the growth of the market in developing countries through their different initiatives, which are aimed at improving regulatory pathways, reimbursement policies, and funding research activities.
• Molecular biology, genomics, and polymerase chain reaction (PCR) technologies have been the big players in drug development and have thus ushered in new types of biotechnological products and applications.
• The biotechnological techniques used in agriculture to increase crop yield and resistance are also a contributing factor to the market’s scope expansion.
• The global biotechnology market is sustained by rising healthcare expenses, infrastructural improvements, and the demand for personalized medicine, along with environmentally friendly bioprocesses.

Market Scope

Opportunity

Precision Medicine

With progress in genomics, proteomics, and bioinformatics, there exists a considerable opportunity to create precision medicine customized to personal genetic profiles. Tailored therapies can improve treatment effectiveness, minimize side effects, and result in better patient outcomes. Businesses focusing on genetic testing, biomarker identification, and personalized treatment strategies can take advantage of this increasing need. The demand for eco-friendly farming methods offers a significant chance for biotech companies. Creating genetically altered crops that are more resistant to climate change, pests, and illnesses can greatly improve food security.

Market Challenge

Stricter Regulatory Compliance

For biotech firms working globally, managing varied regulatory landscapes in different areas poses a major difficulty. Even with efforts for global standardization, significant discrepancies remain in approval criteria, timelines, and compliance benchmarks among key markets like the European Union, United States, China, and Japan. These differences can greatly influence product development plans, necessitating that companies create clinical trials that meet the needs of various regulatory bodies at once.

Application Insights

The bio-pharmacy segment dominated the biotechnology market in 2024 and is expected to grow at the fastest rate during the forecast period. This is mainly due to the increasing demand for biopharmaceuticals, driven by the increased prevalence of chronic diseases, such as cancer and autoimmune diseases. Ongoing innovation in biopharmaceuticals to discover novel drugs to treat a range of diseases further supports segmental growth. Moreover, rising regulatory approvals for novel biopharmaceuticals contributes to segmental expansion.

Bio-agriculture is the second-largest segment, expanding at a rapid pace in the upcoming period. The growth of the segment is attributed to the increasing focus on enhancing food products. This prompts the need for agricultural biotechnology to improve crop yields. Bio-agriculture offers sustainable solutions by reducing the need for chemical-based pesticides, enhancing crop protection and potential side effects. Moreover, stringent regulations regarding food safety contribute to segmental growth.

Global Biotechnology Market Revenue, By Application, 2022-2024 (USD Billion)

Technology Insights

The tissue engineering and regeneration segment held the largest share of 19.17% in 2024. Tissue engineering and regeneration technologies are finding applications across a broad spectrum of healthcare domains, including orthopedics, cardiology, dermatology, and neurology. The versatility of these approaches in addressing diverse medical needs further strengthens their dominance in the biotechnology market. Regulatory agencies worldwide are increasingly recognizing the potential of tissue engineering and regeneration technologies and providing support for their development and commercialization. Clinical validation through successful trials and regulatory approvals has bolstered confidence in these approaches, paving the way for their widespread adoption and market dominance.

The chromatography segment is observed to grow at the fastest CAGR of 15.1% during the forecast period. Chromatography techniques offer unparalleled analytical precision, allowing biotechnologists to separate and analyze complex mixtures of biomolecules with high resolution and accuracy. This precision is crucial for various applications in biotechnology, including drug discovery, proteomics, genomics, and quality control. Chromatography techniques, particularly affinity chromatography, ion exchange chromatography, and size exclusion chromatography, are essential for protein purification in biotechnology research and production. These techniques enable the isolation and purification of target proteins from complex biological matrices, facilitating downstream applications in biopharmaceuticals, diagnostics, and research.

Global Biotechnology Market Revenue, By Technology, 2022-2024 (USD Billion)

Regional Insights

U.S. Biotechnology Market Size and Growth 2025 to 2034

The U.S. biotechnology market size was estimated at USD 277.67 billion in 2024 and is predicted to be worth around USD 1,028.07 billion by 2034, at a CAGR of 14% from 2025 to 2034.

Based on the region, the North American region dominated the global biotechnology market with revenue share in 2024. Several factors, including the existence of important competitors, strong R&D initiatives, and high healthcare expenses, have contributed to the North America region market growth. Furthermore, a growing number of businesses operating in the region are gaining drug approvals, which is fueling market expansion.

The Asia-Pacific is estimated to hit a growth rate of over 14.8% during the forecast period. The improvement of healthcare infrastructure, clinical trial services, and supportive government regulations are all contributing to the Asia-Pacific biotechnology market growth. Moreover, the international market players are partnering actively with local companies in order to accelerate the biotechnology market’s growth.

U.S. Biotechnology Market Trends

The U.S. biotechnology sector is swiftly expanding owing to the persistent demand from multiple industries, such as healthcare, food and beverages, agriculture, pharmaceuticals, fermentation, natural resources and environment, biofuels, and others. A variety of valuable products have been created due to the diverse applications of biotechnology. Biotechnology involves utilizing biological principles to develop innovative products, processes, and organisms aimed at improving society and human health. Advancements in contemporary biotechnology are allowing us to combat rare and debilitating illnesses, reduce our environmental footprint, nourish the impoverished, consume less energy and cleaner resources, and enhance the safety, effectiveness, and cleanliness of industrial manufacturing methods. The biotechnology sector in the U.S. is advancing rapidly and has vast potential to tackle significant global challenges and improve living standards worldwide. 

China Biotechnology Market Trends

The biotechnology market in China is undergoing substantial expansion and is emerging as a key contributor to worldwide innovation. This expansion is driven by robust government backing, heightened R&D funding, and a rise in new drug approvals and licensing agreements. Cities such as Hangzhou and Suzhou are emerging as important biotech centers, promoting innovation and drawing investment. Initiated in 2016, the Healthy China 2030 program establishes bold goals, with the intention of raising the nation's health service sector to a worth of $2 billion (16 trillion yuan) by 2030. It closely aligns with previous initiatives such as the Made in China 2025 strategy, which considered biopharmaceuticals as one of ten essential sectors for national growth. China's investment in biopharma research and development (R&D) has increased at an extraordinary pace. In 2023, China's overall biopharma research and development spending hit $15 billion, a significant rise from only $35 million in 2015.

Europe

Europe biotechnology market is growing at notable CAGR. The European Union (EU) establishes a regulatory framework for biotechnology advancements, guaranteeing safety, effectiveness, and quality benchmarks for agricultural biotechnology items, biopharmaceuticals, and genetically modified organisms. The integration of biotechnology with digital technologies like artificial intelligence, machine learning, and big data analysis offers prospects for innovation and market expansion. European biotech firms can utilize digital biotechnology tools to improve drug discovery and development workflows, streamline healthcare services, and reveal new understandings of disease mechanisms, boosting efficiency and market competitiveness.

• Quotient Therapeutics, originating from the venture capital firm Flagship Pioneering, had its $50 million launch at the end of year 2023. The recently established genomics sequencing firm, based in England, has developed a genetic library platform that will assist in drug discovery. Quotient’s somatic genomics platform aims to uncover the connections between genes and diseases to create therapies that can mimic or block drug targets – the proteins responsible for the disease-associated genes.

How is North America leading in the Biotechnology Market?

Due to a strong R&D ecosystem, advanced healthcare infrastructure, and high genomic research adoption, North America leads the biotechnology market. The market growth is further supported by favorable regulatory frameworks and personalized medicine investments. The strongly built presence of leading biotech firms and a highly skilled labor force also continues to cause the region in the biopharmaceuticals, diagnostics, and agricultural biotechnology sectors to innovate and develop continually.
 
What are the driving factors of the Biotechnology Market in Europe?

Europe is a prominent market for biotechnology, supported by its pharmaceutical and life sciences industries that are well-established. The region's heavy focus on research funding, sustainability, and biomanufacturing innovation is are factors that support technological progress. The cooperation between academia and the private sector helps to progress in gene therapy, molecular diagnostics, and agri-tech, thus keeping Europe a major player in the global biotechnology arena.

How is Asia-Pacific performing in the Biotechnology Market?

Asia-Pacific is expected to be the fastest-growing region in the biotechnology market, with government initiatives, upsurge of healthcare spending, and a thriving biotechnology startup ecosystem as the major factors. China, Japan, and India are among the countries investing in genomics, biopharmaceuticals, and agricultural innovations. Through better healthcare access, more people wanting cheaper therapeutics and faster-moving scientific breakthroughs in molecular biology, the region's biotechnology industry is growing quite dynamically.

United States Biotechnology Market Trends:

With its robust innovation ecosystem, considerable R&D investment, and top-notch institutions, the United States is in the top position of the global biotechnology market. Its main areas of interest are personalized medicine, genetic research, and the production of new biopharmaceuticals, which cause the technological breakthroughs to be so continuous. The US is the center of biotech innovation and commercialization through the cooperation of the academic and industrial spheres that speed up the discovery process.
 
China Biotechnology Market Trends:

China is not the only one in the Asia-Pacific region that benefits from the government's support, better research infrastructure, and larger private investments; it is a major player in the biotechnology market, too. The country is making fast inroads into genomics, precision medicine, and agricultural biotechnology, among others. The strategic policies and the industrial modernization initiatives continue to attract global partners, thereby reinforcing China's position as a major biotech center in the region.
 
India Biotechnology Market Trends:

India's biotechnology sector is experiencing a rapid increase in its market size, which is influenced heavily by its main bioeconomy focus, expanding pharmaceutical base, and government-backed innovation programs. The country is globally competitive in biopharmaceutical manufacturing, vaccines, and agricultural biotechnology. The rising healthcare investment and skilled workforce are supporting India's position as a leading biotechnology innovator in emerging markets.

Japan and South Korea Biotechnology Market Trends:

Japan and South Korea are the biggest players in the Asian biotechnology scene, thanks to their strong R&D capabilities and personalized medicine. Japan is the leader in regenerative medicine and genetic therapies, while South Korea invests a lot in biopharmaceutical production and bioinformatics. The governments of both countries support them, and their technological sophistication helps them to achieve steady growth and innovation.

Biotechnology Market Companies

• Lonza
• AstraZeneca
• Pfizer Inc.
• Gilead Sciences Inc.
• F. Hoffmann-La Roche Ltd.
• Biogen
• CELGENE Corporation
• Sanofi
• Abbott
• Novartis AG

Recent Developments 

• In May 2025, Layn Natural Ingredients has recently launched an upgraded biotechnology facility, which will greatly improve the company's abilities in precision fermentation and enzyme manufacturing. The initial innovation to come from the facility is Galacan, an advanced beta glucan. The company states that, in contrast to beta glucans sourced from oats, yeast, algae, or mushrooms, Galacan is produced through precision fermentation, resulting in a distinct spiral-shaped heteropolysaccharide.
• In May 2025, Nestlé announced a strategic overhaul of its worldwide R&D activities, featuring improved proficiency in biotechnology and the establishment of a new deep tech center in Orbe, located in the canton of Vaud. These modifications seek to enhance the company's innovation pipeline and improve operational efficiency.
• In January 2025, Biosphere, a startup creating innovative bioproduction systems, has come out of stealth  with the introduction of a revolutionary UV-sterilized bioreactor. This innovation represents a significant breakthrough for industrial biotechnology, enabling a substantial decrease in the capital intensity that has hindered the sector for many years.

Value Chain Analysis:

• R&D: The initial stage, which includes the discovery, research, and development of new drugs, medical devices, or diagnostic tools.
  Key Players: Pfizer, Johnson & Johnson, Roche, Novartis
• Clinical Trials and Regulatory Approvals: Conducting exhaustive human testing to determine safety and effectiveness, and then getting governmental permission for marketing the product.
  Key Players: IQVIA, ICON plc, LabCorp, Parexel, and Syneos Health
• Formulation and Final Dosage Preparation: The process of making drugs like tablets or injections that are stable and ready for patients through the combination of active substances and excipients.
  Key Players: Pfizer, Novartis, Roche, and Merck & Co.
• Packaging and Serialization: The process of assigning unique identifiers to each unit to ensure traceability, authenticity, and compliance with the global quality standards.
  Key Players: Amcor, AptarGroup, Nipro Pharma Packaging
• Distribution to Hospitals, Pharmacies: Logistics management to guarantee the biotech products' daily and safe delivery to the healthcare providers and retailers.
  Key players: McKesson Corporation, AmerisourceBergen 
• Patient Support and Services: Strengthening treatment adherence, providing patient education, and offering technical support as part of post-sale programs to enhance patient outcomes.
  Key players: HealthPlix Technologies and BestDoc

Segments Covered in the Report

By Application

• Bio-pharmacy
• Bio-industries
• Bio-services
• Bio-agriculture
• Bio-informatics

By Technology

• Fermentation
• Tissue Engineering and Regeneration
• Polymerase Chain Reaction (PCR) Technology
• Nanobiotechnology
• Chromatography
• Deoxyribonucleic Acid (DNA) Sequencing
• Cell Based Assay
• DNA Sequencing
• Others

By Geography

• North America
• Europe
• Asia-Pacific
• Rest of the World